双三元体PSMA治疗平台使PET成像和前列腺癌的光学检测成为可能
Yimin Chen1, Haonan Yu2, Wanjia Liu1
1Key Laboratory of Radiopharmaceuticals, Ministry of Education, College of Chemistry, Beijing Normal University, Beijing 100875, China.
Journal of medicinal chemistry
|June 4, 2025
概括
一个新的双三前列腺特异性膜抗原 (PSMA) 向系统增强了前列腺癌 (PCa) 诊断的成像. 在临床前和人体研究中,这种治疗平台显示了瘤检测和保留的改善.
科学领域:
- 核医学是一种核医学.
- 放射化学 放射化学是指辐射化学.
- 在瘤学瘤学.
背景情况:
- 目前的前列腺癌 (PCa) 成像剂缺乏最佳的灵敏度和对比度.
- 前列腺特异性膜抗原 (PSMA) 是PCa检测的关键生物标志物.
研究的目的:
- 开发和评估一种新型的双三基PSMA向的治疗系统,以改善PCa诊断.
- 在临床前和人体研究中评估新探针的诊断性能.
主要方法:
- 一系列双三基PSMA探针 (PSMA-T0-T6) 的合成,使用不同的链接器.
- 在瘤携带小鼠中使用[68Ga]Ga-PSMA-T3进行临床前评估,将摄取量和瘤与背景比率 (TBR) 与[68Ga]Ga-PSMA-11进行比较.
- 对光学成像剂 (ICG结合的PSMA-T6) 对瘤保留和特异性的评估.
- 这是首次在人体上使用[68Ga]Ga-PSMA-T3.3的正子发射断层扫描 (PET) 研究.
主要成果:
- 合成的探针显示出高的PSMA亲和力 (Ki = 0.11-0.60 nM).
- [68Ga]Ga-PSMA-T3在临床前模型中表现出比[68Ga]Ga-PSMA-11更高的瘤吸收率和TBR.
- 在ICG-PSMA-T6中,瘤保留时间长,活体特异性高.
- 人类PET研究证实[68Ga]Ga-PSMA-T3对初级和转移性病变的可比或增强的检测率,特别是在肝脏和骨中,具有更高的TBR.
结论:
- 双三基PSMA平台为前列腺癌提供了增强的诊断灵敏度.
- 这种术后感系统显示出改善PCa检测和手术内管理的巨大潜力.
更多相关视频
相关概念视频
Positron Emission Tomography
5.9K
Positron emission tomography (PET) is a medical imaging technique involving radiopharmaceuticals — substances that emit short-lived radiation. Although the first PET scanner was introduced in 1961, it took 15 more years before radiopharmaceuticals were combined with the technique and revolutionized its potential.
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
One of the main requirements of a PET scan is a positron-emitting radioisotope, which is produced in a cyclotron and then attached to a substance used by the part of the body...
5.9K
Imaging Studies II: Positron Emission Tomography and Scintigraphy
241
Positron Emission Tomography (PET) is a medical imaging technique that provides crucial insights into the body's physiological functions at a molecular level. It is an indispensable resource for diagnosing, staging, and monitoring various illnesses, notably cancer, neurological disorders, and cardiovascular conditions.
Fundamental Principles of PET
Fundamental Principles of PET
241


